1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Naik, M.T.
Huang, T.H.
Shih, H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Mol.Cell
MOCEFL
2168
1097-2765
42
62
74
10.1016/j.molcel.2011.02.022
21474068
Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation.
2011
11293.674
Small ubiquitin-related modifier 1
1
man
polymer
2295.456
Death domain-associated protein 6
UNP residues 721-741
1
syn
polymer
SUMO-1, Sentrin, Ubiquitin-like protein SMT3C, SMT3 homolog 3, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein UBL1, GAP-modifying protein 1, GMP1
Daxx, hDaxx, Fas death domain-associated protein, ETS1-associated protein 1, EAP1
no
no
GSMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPK
ELGMEEEDVIEVYQEQTGG
GSMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPK
ELGMEEEDVIEVYQEQTGG
A
polypeptide(L)
no
no
GSKTSVATQCDPEEIIVLSDSD
GSKTSVATQCDPEEIIVLSDSD
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
OK/SW-cl.43, SMT3C, SMT3H3, SUMO1, UBL1
9606
Homo sapiens
562
Escherichia coli
BL21(DE3)
pGex-4T1
This entry describes the solution structure of complex between Small Ubiquitin like Modifier -1 (SUMO-1) and the synthetic peptide derived from the C-terminal SUMO Interacting Motif (SIM) of Death Associated Protein -6.
repository
Initial release
Version format compliance
Database references
1
0
2010-12-01
1
1
2011-07-13
1
2
2013-08-21
Solution structure of complex between SUMO-1 and SIM from PIASx
Solution structure of complex between SUMO-3 and SIM from MCAF1
BMRB
Y
PDBJ
2009-11-17
REL
REL
The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human)
9606
human
Homo sapiens
sample
2087
690
692
303
520
0
22
109
109
structures with the lowest energy
500
20
1
2D 1H-15N HSQC
2D 1H-13C HSQC
3D HNCA
3D HNCACB
3D CBCA(CO)NH
3D HNCO
3D 1H-15N TOCSY
3D HCCH-COSY
3D CCH-TOCSY
3D 1H-15N NOESY
3D 1H-13C NOESY
3D 1H-15N NOESY - F1 filtered
3D 1H-13C NOESY - F1 filtered
3D HNHA
2D 1H-15N HSQC - IPAP
0.27-0.5
mM
[U-100% 15N]
0-1.7
mM
10
mM
100
mM
2
mM
0.1
mM
0.001
%
0.5
mM
[U-100% 13C; U-100% 15N]
2
mM
10
mM
100
mM
2
mM
0.1
mM
0.001
%
2
mM
0.5
mM
[U-100% 13C; U-100% 15N]
10
mM
100
mM
2
mM
0.1
mM
0.001
%
0.5
mM
[U-100% 13C; U-100% 15N]
0.5
mM
[U-100% 13C; U-100% 15N]
10
mM
100
mM
2
mM
0.1
mM
0.001
%
0.0066
w/v
0.1
6.5
ambient
290
K
torsion angle dynamics
1
lowest energy
0.27-0.5mM [U-100% 15N] SUMO1-1, 0-1.7mM DAXX20-2, 10mM potassium phosphate-3, 100mM potassium chloride-4, 2mM DTT-5, 0.1mM EDTA-6, 0.001% sodium azide-7, 90% H2O/10% D2O
90% H2O/10% D2O
0.5 mM [U-100% 13C; U-100% 15N] SUMO1-8, 2mM DAXX20-9, 10mM potassium phosphate-10, 100mM potassium chloride-11, 2mM DTT-12, 0.1mM EDTA-13, 0.001% sodium azide-14, 90% H2O/10% D2O
90% H2O/10% D2O
2 mM SUMO1-15, 0.5mM [U-100% 13C; U-100% 15N] DAXX20-16, 10mM potassium phosphate-17, 100mM potassium chloride-18, 2mM DTT-19, 0.1mM EDTA-20, 0.001% sodium azide-21, 90% H2O/10% D2O
90% H2O/10% D2O
0.5mM [U-100% 13C; U-100% 15N] SUMO1-22, 0.5mM [U-100% 13C; U-100% 15N] DAXX20-23, 10mM potassium phosphate-24, 100mM potassium chloride-25, 2mM DTT-26, 0.1mM EDTA-27, 0.001% sodium azide-28, 0.0066 w/v Pf1 phage-29, 90% H2O/10% D2O
90% H2O/10% D2O
BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN
structure solution
CNS
1.2
BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN
refinement
CNS
1.2
Linge, O'Donoghue and Nilges
structure solution
ARIA
2.2
Linge, O'Donoghue and Nilges
refinement
ARIA
2.2
Bruker Biospin
processing
TOPSPIN
2.1
Bruker Biospin
collection
TOPSPIN
2.1
Goddard
peak picking
SPARKY
3.113
Goddard
chemical shift assignment
SPARKY
3.113
500
Bruker
Avance
Bruker Avance
600
Bruker
Avance
Bruker Avance
800
Bruker
Avance
Bruker Avance
n
1
-1
A
n
2
0
A
MET
1
n
3
MET
1
A
SER
2
n
4
SER
2
A
ASP
3
n
5
ASP
3
A
GLN
4
n
6
GLN
4
A
GLU
5
n
7
GLU
5
A
ALA
6
n
8
ALA
6
A
LYS
7
n
9
LYS
7
A
PRO
8
n
10
PRO
8
A
SER
9
n
11
SER
9
A
THR
10
n
12
THR
10
A
GLU
11
n
13
GLU
11
A
ASP
12
n
14
ASP
12
A
LEU
13
n
15
LEU
13
A
GLY
14
n
16
GLY
14
A
ASP
15
n
17
ASP
15
A
LYS
16
n
18
LYS
16
A
LYS
17
n
19
LYS
17
A
GLU
18
n
20
GLU
18
A
GLY
19
n
21
GLY
19
A
GLU
20
n
22
GLU
20
A
TYR
21
n
23
TYR
21
A
ILE
22
n
24
ILE
22
A
LYS
23
n
25
LYS
23
A
LEU
24
n
26
LEU
24
A
LYS
25
n
27
LYS
25
A
VAL
26
n
28
VAL
26
A
ILE
27
n
29
ILE
27
A
GLY
28
n
30
GLY
28
A
GLN
29
n
31
GLN
29
A
ASP
30
n
32
ASP
30
A
SER
31
n
33
SER
31
A
SER
32
n
34
SER
32
A
GLU
33
n
35
GLU
33
A
ILE
34
n
36
ILE
34
A
HIS
35
n
37
HIS
35
A
PHE
36
n
38
PHE
36
A
LYS
37
n
39
LYS
37
A
VAL
38
n
40
VAL
38
A
LYS
39
n
41
LYS
39
A
MET
40
n
42
MET
40
A
THR
41
n
43
THR
41
A
THR
42
n
44
THR
42
A
HIS
43
n
45
HIS
43
A
LEU
44
n
46
LEU
44
A
LYS
45
n
47
LYS
45
A
LYS
46
n
48
LYS
46
A
LEU
47
n
49
LEU
47
A
LYS
48
n
50
LYS
48
A
GLU
49
n
51
GLU
49
A
SER
50
n
52
SER
50
A
TYR
51
n
53
TYR
51
A
CYS
52
n
54
CYS
52
A
GLN
53
n
55
GLN
53
A
ARG
54
n
56
ARG
54
A
GLN
55
n
57
GLN
55
A
GLY
56
n
58
GLY
56
A
VAL
57
n
59
VAL
57
A
PRO
58
n
60
PRO
58
A
MET
59
n
61
MET
59
A
ASN
60
n
62
ASN
60
A
SER
61
n
63
SER
61
A
LEU
62
n
64
LEU
62
A
ARG
63
n
65
ARG
63
A
PHE
64
n
66
PHE
64
A
LEU
65
n
67
LEU
65
A
PHE
66
n
68
PHE
66
A
GLU
67
n
69
GLU
67
A
GLY
68
n
70
GLY
68
A
GLN
69
n
71
GLN
69
A
ARG
70
n
72
ARG
70
A
ILE
71
n
73
ILE
71
A
ALA
72
n
74
ALA
72
A
ASP
73
n
75
ASP
73
A
ASN
74
n
76
ASN
74
A
HIS
75
n
77
HIS
75
A
THR
76
n
78
THR
76
A
PRO
77
n
79
PRO
77
A
LYS
78
n
80
LYS
78
A
GLU
79
n
81
GLU
79
A
LEU
80
n
82
LEU
80
A
GLY
81
n
83
GLY
81
A
MET
82
n
84
MET
82
A
GLU
83
n
85
GLU
83
A
GLU
84
n
86
GLU
84
A
GLU
85
n
87
GLU
85
A
ASP
86
n
88
ASP
86
A
VAL
87
n
89
VAL
87
A
ILE
88
n
90
ILE
88
A
GLU
89
n
91
GLU
89
A
VAL
90
n
92
VAL
90
A
TYR
91
n
93
TYR
91
A
GLN
92
n
94
GLN
92
A
GLU
93
n
95
GLU
93
A
GLN
94
n
96
GLN
94
A
THR
95
n
97
THR
95
A
GLY
96
n
98
GLY
96
A
GLY
97
n
99
GLY
97
A
n
1
719
B
n
2
720
B
LYS
721
n
3
LYS
721
B
THR
722
n
4
THR
722
B
SER
723
n
5
SER
723
B
VAL
724
n
6
VAL
724
B
ALA
725
n
7
ALA
725
B
THR
726
n
8
THR
726
B
GLN
727
n
9
GLN
727
B
CYS
728
n
10
CYS
728
B
ASP
729
n
11
ASP
729
B
PRO
730
n
12
PRO
730
B
GLU
731
n
13
GLU
731
B
GLU
732
n
14
GLU
732
B
ILE
733
n
15
ILE
733
B
ILE
734
n
16
ILE
734
B
VAL
735
n
17
VAL
735
B
LEU
736
n
18
LEU
736
B
SER
737
n
19
SER
737
B
ASP
738
n
20
ASP
738
B
SER
739
n
21
SER
739
B
ASP
740
n
22
ASP
740
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ILE
34
A
O
ILE
36
A
N
VAL
26
A
N
VAL
28
A
N
LYS
25
A
N
LYS
27
A
O
ILE
88
A
O
ILE
90
A
O
TYR
91
A
O
TYR
93
A
N
ARG
63
A
N
ARG
65
A
N
PHE
66
A
N
PHE
68
A
O
GLN
69
A
O
GLN
71
1
A
GLY
-1
A
GLY
1
1
Y
1
A
SER
0
A
SER
2
1
Y
1
B
GLY
719
B
GLY
1
1
Y
1
B
SER
720
B
SER
2
1
Y
2
A
GLY
-1
A
GLY
1
1
Y
2
A
SER
0
A
SER
2
1
Y
2
B
GLY
719
B
GLY
1
1
Y
2
B
SER
720
B
SER
2
1
Y
3
A
GLY
-1
A
GLY
1
1
Y
3
A
SER
0
A
SER
2
1
Y
3
B
GLY
719
B
GLY
1
1
Y
3
B
SER
720
B
SER
2
1
Y
4
A
GLY
-1
A
GLY
1
1
Y
4
A
SER
0
A
SER
2
1
Y
4
B
GLY
719
B
GLY
1
1
Y
4
B
SER
720
B
SER
2
1
Y
5
A
GLY
-1
A
GLY
1
1
Y
5
A
SER
0
A
SER
2
1
Y
5
B
GLY
719
B
GLY
1
1
Y
5
B
SER
720
B
SER
2
1
Y
6
A
GLY
-1
A
GLY
1
1
Y
6
A
SER
0
A
SER
2
1
Y
6
B
GLY
719
B
GLY
1
1
Y
6
B
SER
720
B
SER
2
1
Y
7
A
GLY
-1
A
GLY
1
1
Y
7
A
SER
0
A
SER
2
1
Y
7
B
GLY
719
B
GLY
1
1
Y
7
B
SER
720
B
SER
2
1
Y
8
A
GLY
-1
A
GLY
1
1
Y
8
A
SER
0
A
SER
2
1
Y
8
B
GLY
719
B
GLY
1
1
Y
8
B
SER
720
B
SER
2
1
Y
9
A
GLY
-1
A
GLY
1
1
Y
9
A
SER
0
A
SER
2
1
Y
9
B
GLY
719
B
GLY
1
1
Y
9
B
SER
720
B
SER
2
1
Y
10
A
GLY
-1
A
GLY
1
1
Y
10
A
SER
0
A
SER
2
1
Y
10
B
GLY
719
B
GLY
1
1
Y
10
B
SER
720
B
SER
2
1
Y
11
A
GLY
-1
A
GLY
1
1
Y
11
A
SER
0
A
SER
2
1
Y
11
B
GLY
719
B
GLY
1
1
Y
11
B
SER
720
B
SER
2
1
Y
12
A
GLY
-1
A
GLY
1
1
Y
12
A
SER
0
A
SER
2
1
Y
12
B
GLY
719
B
GLY
1
1
Y
12
B
SER
720
B
SER
2
1
Y
13
A
GLY
-1
A
GLY
1
1
Y
13
A
SER
0
A
SER
2
1
Y
13
B
GLY
719
B
GLY
1
1
Y
13
B
SER
720
B
SER
2
1
Y
14
A
GLY
-1
A
GLY
1
1
Y
14
A
SER
0
A
SER
2
1
Y
14
B
GLY
719
B
GLY
1
1
Y
14
B
SER
720
B
SER
2
1
Y
15
A
GLY
-1
A
GLY
1
1
Y
15
A
SER
0
A
SER
2
1
Y
15
B
GLY
719
B
GLY
1
1
Y
15
B
SER
720
B
SER
2
1
Y
16
A
GLY
-1
A
GLY
1
1
Y
16
A
SER
0
A
SER
2
1
Y
16
B
GLY
719
B
GLY
1
1
Y
16
B
SER
720
B
SER
2
1
Y
17
A
GLY
-1
A
GLY
1
1
Y
17
A
SER
0
A
SER
2
1
Y
17
B
GLY
719
B
GLY
1
1
Y
17
B
SER
720
B
SER
2
1
Y
18
A
GLY
-1
A
GLY
1
1
Y
18
A
SER
0
A
SER
2
1
Y
18
B
GLY
719
B
GLY
1
1
Y
18
B
SER
720
B
SER
2
1
Y
19
A
GLY
-1
A
GLY
1
1
Y
19
A
SER
0
A
SER
2
1
Y
19
B
GLY
719
B
GLY
1
1
Y
19
B
SER
720
B
SER
2
1
Y
20
A
GLY
-1
A
GLY
1
1
Y
20
A
SER
0
A
SER
2
1
Y
20
B
GLY
719
B
GLY
1
1
Y
20
B
SER
720
B
SER
2
1
Y
1
A
A
HZ1
OE1
LYS
GLU
46
49
1.59
1
A
B
HZ2
OD2
LYS
ASP
39
740
1.59
2
A
B
HD3
HG13
ARG
ILE
54
733
1.10
2
A
B
HG2
HB3
LYS
ASP
39
740
1.27
2
A
A
HZ3
OE1
LYS
GLU
23
84
1.54
3
A
B
HD3
HG12
ARG
ILE
54
733
1.31
3
A
A
HD1
OE1
HIS
GLU
75
79
1.57
3
A
A
O
HZ2
TYR
LYS
21
37
1.59
4
A
A
HD1
HD2
TYR
LYS
21
37
1.26
4
A
B
HE21
HD11
GLN
ILE
55
733
1.33
4
A
B
HG
OE1
SER
GLU
32
731
1.59
5
A
A
HA
HB2
MET
GLU
1
5
1.21
5
A
B
HG2
HB2
LYS
ASP
39
738
1.25
5
A
A
HE
OE2
ARG
GLU
63
93
1.58
6
A
A
HZ2
HH
LYS
TYR
17
21
1.32
7
A
A
HE2
HB2
PHE
SER
36
50
1.22
7
A
B
HD3
HG13
ARG
ILE
54
733
1.28
8
A
A
HB2
HE21
ASP
GLN
3
4
1.22
8
A
B
HD3
HG12
ARG
ILE
54
733
1.33
8
A
A
OD1
H
ASP
GLN
3
4
1.56
9
A
A
HD1
OE1
HIS
GLU
75
79
1.59
10
A
A
HD3
HB3
LYS
HIS
23
35
1.31
11
A
B
HG2
HB3
LYS
ASP
39
740
1.27
11
A
A
HD1
OE1
HIS
GLU
75
79
1.59
12
A
A
OD2
HZ1
ASP
LYS
12
16
1.60
13
A
B
HZ3
OD1
LYS
ASP
39
738
1.51
13
A
A
HZ3
OD1
LYS
ASP
45
73
1.54
13
A
A
O
HG
ASP
SER
30
31
1.59
13
A
A
HZ3
OE2
LYS
GLU
48
93
1.60
14
A
B
HD3
HG13
ARG
ILE
54
733
1.26
15
A
B
HD3
HG12
ARG
ILE
54
733
1.29
15
A
B
HD2
HB2
LYS
ASP
39
738
1.31
16
A
B
HD3
HG13
ARG
ILE
54
733
1.32
16
A
A
HZ1
OE2
LYS
GLU
37
84
1.56
18
A
A
HZ2
HH
LYS
TYR
17
21
0.97
18
A
B
HD3
HG13
ARG
ILE
54
733
1.25
19
A
B
HD3
HG12
ARG
ILE
54
733
1.28
20
A
B
HD3
HG13
ARG
ILE
54
733
1.13
19
A
TYR
51
0.051
SIDE CHAIN
7
A
A
CE1
CZ
TYR
TYR
91
91
-0.082
0.013
1.381
1.299
N
1
A
GLN
4
-125.79
-91.92
1
A
ASP
12
-128.17
-59.70
1
A
LYS
16
-74.94
-95.39
1
A
LYS
17
-114.35
-94.60
1
A
SER
31
74.54
-0.89
1
B
PRO
730
-85.92
-149.17
2
A
GLN
4
-99.41
32.91
2
A
PRO
8
-88.60
37.48
2
A
LYS
16
-116.02
-80.54
2
A
LYS
17
-101.05
-93.48
2
A
GLU
18
-179.39
-172.54
2
A
GLN
94
-131.39
-159.03
3
A
SER
2
-84.30
-80.67
3
A
GLN
4
-113.25
-87.05
3
A
GLU
5
-110.00
-68.92
3
A
PRO
8
-79.63
31.31
3
A
ASP
12
-93.84
32.99
3
A
SER
31
68.53
-15.22
3
A
GLN
94
-140.67
-159.48
4
A
ASP
3
-129.42
-76.92
4
A
PRO
8
-72.34
43.54
4
A
GLU
11
-76.48
24.93
4
A
LYS
17
-96.43
-71.92
4
A
GLN
94
-132.69
-157.12
4
B
PRO
730
-61.03
-165.78
5
A
SER
2
-76.15
-95.09
5
A
PRO
8
-81.81
32.88
5
A
LYS
17
-87.12
-75.39
5
A
ARG
70
-58.48
109.18
5
B
PRO
730
-75.38
-159.82
6
A
LYS
7
-38.06
118.37
6
A
SER
9
-140.41
11.48
6
A
THR
10
-137.37
-68.61
6
A
LYS
17
-102.00
-62.74
6
A
SER
31
71.97
-0.62
6
A
GLN
94
-120.91
-169.23
7
A
PRO
8
-73.38
46.46
7
A
LYS
17
-102.14
-94.78
7
A
SER
31
72.53
-5.87
7
A
GLN
94
-114.12
-160.92
7
B
PRO
730
-78.24
-156.21
8
A
ASP
3
-111.28
-77.31
8
A
GLN
4
-125.88
-55.60
8
A
ASP
12
-90.45
32.43
8
A
LYS
16
-88.19
-82.94
8
A
SER
31
71.78
-11.58
9
A
THR
10
-80.55
-75.41
9
A
ASP
15
-125.92
-51.69
9
A
LYS
17
-90.57
-87.18
9
A
GLN
94
-163.50
-155.56
10
A
SER
2
-101.84
-69.31
10
A
ASP
3
-130.40
-65.44
10
A
PRO
8
-85.35
49.44
10
A
LYS
17
-47.74
-94.56
10
A
SER
31
78.45
-15.12
10
A
GLN
94
-125.03
-154.91
11
A
PRO
8
-94.56
43.82
11
A
THR
10
-139.18
-72.97
11
A
GLU
11
-132.12
-81.41
11
A
LEU
13
-66.67
-179.72
11
A
LYS
17
-61.28
-77.64
11
A
GLN
94
-136.70
-156.31
12
A
GLU
5
-90.88
44.02
12
A
ALA
6
-65.75
-173.29
12
A
SER
31
69.27
-5.52
12
A
THR
41
-105.51
40.91
12
A
GLN
94
-114.75
-163.20
12
B
PRO
730
-69.70
27.34
13
A
PRO
8
-90.08
40.49
13
A
LYS
17
-76.03
-71.81
13
A
SER
31
73.17
-2.34
13
A
GLN
94
-120.96
-161.62
13
B
PRO
730
-80.73
-158.05
14
A
ASP
12
-89.88
35.54
14
A
SER
31
76.67
-10.91
14
A
GLN
94
-138.71
-152.24
14
A
THR
95
-34.80
-156.89
15
A
PRO
8
-83.85
44.50
15
A
LEU
13
-68.47
-177.28
15
A
GLN
94
-123.03
-164.63
16
A
SER
9
-140.41
14.94
16
A
THR
10
-126.45
-71.07
16
A
LYS
17
-73.06
-79.58
16
A
SER
31
73.76
-0.96
16
A
GLN
94
-121.17
-156.13
17
A
GLN
4
-69.95
-70.39
17
A
GLU
5
-132.59
-78.08
17
A
PRO
8
-91.82
30.02
17
A
ASP
12
-92.79
32.67
17
A
LYS
16
-78.96
-86.94
17
A
SER
31
80.32
-15.07
17
A
GLU
85
80.11
19.84
17
A
GLN
94
-129.26
-163.83
17
B
PRO
730
-77.14
-158.91
18
A
ALA
6
-69.87
93.16
18
A
PRO
8
-98.01
41.64
18
A
LYS
17
-49.96
-81.49
18
A
GLN
94
-158.07
-159.87
19
A
SER
2
-75.41
-81.02
19
A
ASP
3
-129.50
-87.99
19
A
GLN
4
-124.97
-84.50
19
A
GLU
5
-109.37
42.69
19
A
LYS
17
-27.97
-60.12
19
A
SER
31
75.27
-14.85
19
A
GLN
94
-118.89
-161.72
20
A
SER
2
-123.60
-93.83
20
A
GLN
4
-115.05
-87.54
20
A
GLU
5
-132.45
-82.64
20
A
LYS
16
-112.99
-94.65
20
A
GLU
18
-124.81
-164.06
20
A
SER
31
75.64
-4.76
20
A
GLN
94
-100.59
-155.68
20
B
PRO
730
-79.56
-166.48
Small ubiquitin-related modifier 1, Death domain-associated protein 6
lowest energy, model 1
Phosphorylation of SUMO-interacting motif by CK2 enhances Daxx SUMO binding activity
1
N
N
2
N
N
A
HIS
43
A
HIS
45
HELX_P
A
GLY
56
A
GLY
58
1
1
14
A
THR
76
A
THR
78
HELX_P
A
GLY
81
A
GLY
83
1
2
6
TRANSCRIPTION, APOPTOSIS
SUMO, SIM, Daxx, Nucleus, Phosphoprotein, Ubl conjugation pathway, Apoptosis, Transcription, Transcription regulation
SUMO1_HUMAN
UNP
1
1
P63165
MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKEL
GMEEEDVIEVYQEQTGG
DAXX_HUMAN
UNP
2
721
Q9UER7
KTSVATQCDPEEIIVLSDSD
1
97
2KQS
1
97
P63165
A
1
3
99
721
740
2KQS
721
740
Q9UER7
B
2
3
22
1
EXPRESSION TAG
GLY
-1
2KQS
A
P63165
UNP
1
1
EXPRESSION TAG
SER
0
2KQS
A
P63165
UNP
2
2
EXPRESSION TAG
GLY
719
2KQS
B
Q9UER7
UNP
1
2
EXPRESSION TAG
SER
720
2KQS
B
Q9UER7
UNP
2
5
anti-parallel
parallel
anti-parallel
anti-parallel
A
GLU
33
A
GLU
35
A
VAL
38
A
VAL
40
A
ILE
22
A
ILE
24
A
ILE
27
A
ILE
29
A
ASP
86
A
ASP
88
A
GLN
92
A
GLN
94
A
LEU
62
A
LEU
64
A
PHE
66
A
PHE
68
A
GLN
69
A
GLN
71
A
ARG
70
A
ARG
72